CMS’ drug price negotiations are advancing, but new indications and exclusivity rules could complicate future pricing cycles. CMS gained the authority to negotiate list prices with drug manufacturers ...

For decades, pharmaceutical companies have shelled out big bucks to broadcasters to place ads between segments. But a pair of ...

WASHINGTON — Trump administration officials are expected to release more details on their plan to lower prescription drug ...

President Donald Trump’s proposal to peg American drug costs to prices paid in other countries risks upending Medicaid’s drug ...

Pharmaceutical giant Eli Lilly announced a price cut for its drug, Zepbound, for people who aren't using insurance. CBS News' ...

Trump is correct. Too many drug prices are too high. How pharmacy benefit managers help inflate the prices of drugs in ...

President Trump just issued an executive order to rebalance the global pharmaceutical market — by tying U.S. drug prices to ...

Medicaid doesn’t need price controls from other countries; it already imposes them here. Under the program’s existing “Best ...

Pfizer and other drug companies have met with the Trump administration to discuss lowering U.S. drug prices but no ...

The Trump administration had said it would disclose by Wednesday the target prices for drugs, but pharma companies are still ...

Drug pricing has been under increased scrutiny under both the Trump and Biden administrations, including changes to cap ...

To help keep drug prices reasonable, the legislature should reign in the middlemen that help drive up prices, this guest ...